Case 17- TB and lymphoid organs Flashcards
TB and HIV
It is the leading cause of death among people with HIV, it causes one in three AIDs related deaths
Causative agent of TB
TB is caused by bacteria of the Mycobacterium tuberculosis complex- mainly Mycobacterium tuberculosis, rarely Mycobacterium bovis.
TB transmission
Through the respiratory route from those with infectious active pulmonary TB coughs
Classifying the Mycobacterium tuberculosis complex
Aerobic rods, occasionally form branched filaments. The gram stain does not work, the acid fast staining process is used and is often referred to as acid fast bacteria, stain gives them a deep purple colour. Mycobacteria have a lipid rich cell wall (major pathogenicity factor).
Epidemiology of TB
1) V high rates in subsaharan Africa, South East Asia
2) HIV with TB is most common in sub-saharan Africa
3) UK is a low incidence country
4) There is a slow decrease in TB cases and overall deaths worldwide
5) TB is one of the top 10 causes of death worldwide, multi-drug resistant TB has started to develop
What is TB associated with in England
People born outside the UK account for 72% of TB notifications, TB is associated with deprivation.
TB- what happens after primary exposure
After exposure to the primary case of TB about 70% of people will have no infection. Of those infected over 90% will have immune activation and granuloma formation and then latency. In immunocompromised people (<10%) there will be reactivation of TB leading to the active disease. Its far greater in those with HIV. There will be failure of immune activation and this leads to the primary disease (active disease).
Clinical features of TB- the 4 different types
- Active pulmonary TB- the most common presentation
- Active extrapulmonary TB- presents with symptoms specific to the site involved (CNS/ Lymph nodes/ Bones and joints/ Pericardium/ GU). Can get spinal TB, infection of the lymph nodes and granuloma formation.
- Latent TB- occurs when the Mycobacterium bacteria remains dormant and is asymptomatic, reactivation in about 10% of cases
- Multidrug resistant TB- refers to a strain of TB that is resistant to two first line drugs
Risk factors for TB
- Being born in high prevalence areas
- Close contact with TB
- Previously (especially incomplete) treatment for TB
- Comorbidities
- Social risk factors
- Alcohol or drug misuse
When should you suspect TB
In patients who have a high risk of developing TB and have general symptoms of weight loss, fever, night sweats, anorexia and malaise
When should you consider pulmonary involvement in TB
Once other things have been rules out- persistent productive cough, breathlessness and haemoptysis
Pulmonary TB
Causes destruction of lung tissue, there will be abnormal x-rays with considerable scarring. There can be granuloma formation in the lungs
Latent TB
- Initial stage of TB infection causes the innate immune response followed by the adaptive immune response.
- Recruitment of T cells, B cells, activated macrophages and other leukocytes leads to the establishment of granulomas, less likely to happen in HIV.
- Granulomas are cellular aggregates which are pathologic hallmarks of tuberculosis thought necessary for containment of infection. It restrains and contains the infection
- Most infected individuals will remain in the latent state of infection
- <10% will progress to active disease when granulomas have eroded into the airway. Transmissive granuloma
Miliary tuberculosis
Very rare, characterised by wide dissemination. There will be tiny spots on the chest x-ray, can disseminate to other tissues, fatal if untreated
TB clinical features- latent and active
- Latent- asymptomatic, non-infective, positive skin test or blood test for indicating TB infection, normal chest x-ray and a negative sputum smear, needs treatment for latent TB
- Active- symptomatic, infective, positive skin test or blood test for indicating TB infection, abnormal chest x-ray or positive sputum smear or culture, needs treatment for active TB disease
Treatment for active TB
Active antibiotic drug treatment with combination regimens:
• Usually 6 months of isoniazid (with pyridoxine) and rifampicin
• Supplemented in the first 2 months with pyrazinamide and ethambutol
You tend to stop treatment when there is a negative smear or culture
Treatment for latent TB
- 3 months with isoniazid (with pyridoxine) and rifampicin, or
- 6 months of isoniazid (with pyridoxine)
Completing TB treatment
15% of patients do not complete their course of treatment. Patients should complete treatment to reduce the risk of: • Drug resistant TB • Onward transmission • Relapse of disease • Dying
Problems of TB treatment (resistance)
- Mono-resistance= resistance to one first line anti-TB drug only
- Poly-resistance= resistance to more than one first line anti-TB drug, other than both isoniazid and rifampicin
- Multidrug resistance (MDR)= resistance to at least both isoniazid and rifampicin
- Extensive drug resistance (XDR)= resistance to any fluoroquinolone and at least one of the three second line injectable in addition to multidrug resistance.
Issues with MDR TB
Limited and expensive treatment options, poor availability of second line treatment. Adverse side effects